RANBP2

E3 SUMO-protein ligase RanBP2 · P49792 · RANBP2 on Sugi Atlas →

0 patent compounds predicted against RANBP2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RANBP2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Evaluation of Corticosteroid in Systemic Inflammatory Response Syndrome PHASE4COMPLETED
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS) PHASE2COMPLETED
GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia PHASE1COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections nanCOMPLETED
MEHMO Natural History and Biomarkers nanRECRUITING
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma(SELINA) nanRECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study nanACTIVE_NOT_RECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) nanCOMPLETED
Value of MicroRNA30a in Philadelphia Positive Leukemic Patients nanUNKNOWN
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth nanCOMPLETED
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders nanRECRUITING
APAP Hepatotoxicity After Therapeutic Doses nanUNKNOWN
Genetics of Familial and Sporadic ALS nanCOMPLETED
Shwachman Diamond Syndrome Registry and Study nanRECRUITING
Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults nanCOMPLETED
Pleiotropy and Mechanism of Peripheral Nerve Related Genes in the Progression of Amyotrophic Lateral Sclerosis nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas nanRECRUITING
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis nanUNKNOWN
Biological Signatures Resulting From Occupational Exposure to Complex Mixtures of PAHs nanUNKNOWN
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a RANBP2 binder may also engage these)

ProteinNameSimilarity
H2QII6 1.000 H2QII6 →
Q9ERU9 1.000 Q9ERU9 →
O14715 1.000 O14715 →
Q99666 1.000 Q99666 →
Q7Z3J3 0.997 Q7Z3J3 →
P0DJD1 0.996 P0DJD1 →
P0DJD0 0.996 P0DJD0 →
Q18892 0.995 Q18892 →
A6NKT7 0.994 A6NKT7 →
A0A0B4K7J2 0.994 A0A0B4K7J2 →
A1Z8X3 0.994 A1Z8X3 →
G5ED39 0.993 G5ED39 →
Q9DE14 0.993 Q9DE14 →
P45964 0.993 P45964 →
Q21920 0.993 Q21920 →
P32333 0.992 P32333 →
Q0VF22 0.992 Q0VF22 →
Q811D2 0.992 Q811D2 →
ATR Serine/threonine-protein kinase ATR 0.992 landscape →
Q5MNV8 0.992 Q5MNV8 →
Q4V847 0.992 Q4V847 →
Q9SXA1 0.992 Q9SXA1 →
O65020 0.992 O65020 →
Q8BKX6 0.992 Q8BKX6 →
PHKB Phosphorylase kinase beta subunit 0.992 landscape →
P42173 0.991 P42173 →
Q1LXZ9 0.991 Q1LXZ9 →
Q6FS52 0.991 Q6FS52 →
O08662 0.991 O08662 →
Q61WP7 0.991 Q61WP7 →